An Aspirin a Day May Still Lower Cancer Risk, but Not as Much as Previously Thought
A new study offers fresh evidence that popping a daily aspirin is associated with a lower risk of dying from cancer, but the size of the potential protective effect may be smaller than previous research has suggested
By Alexandra Sifferlin. In TIME
Radiation after lumpectomy helps prevent need for mastectomy in early stage breast cancer
Contrary to clinical recommendations, older women with early stage breast cancer may want to undergo radiation after lumpectomy to help ensure that they will not need a mastectomy in the future. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The findings indicate that current thinking on the risks and benefits of radiation for early stage breast cancer in older women may be inaccurate.
In Science Codex
Early Breast Cancer in Older Women: Mastectomies Avoidable for Some
A study published in Cancer, the journal of the American Cancer Society, provides evidence that older women with early-stage breast cancer who undergo radiation therapy following a lumpectomy are less likely to require a subsequent mastectomy. This is contrary to current recommendations that suggest radiation therapy does not play a role in determining whether an older woman will need a mastectomy following a lumpectomy for her early-stage breast cancer. The authors suggest the current recommendations are based on inaccurate thinking of the risks and benefits of radiation therapy.
By Anna Azvolinsky. In Cancer Network
Komen's Leadership Changes Are Met With Skepticism
Leadership changes at the Susan G. Komen Foundation for the Cure six months after an online uproar over a decision to cut funds for breast cancer screenings at Planned Parenthood was greeted with skepticism on Thursday among breast cancer advocates and longtime former supporters.
By Jennifer Preston. In New York Times (blog)
Screening Debate Typifies Prostate Cancer Uncertainties
Experts differ, leaving men with no easy answers.
By Serena Gordon. In
News & World Report U.S.
La surcharge pondérale favorise (aussi) les seconds cancers
Combattre le surpoids permet de réduire le risque de développer une deuxième tumeur, voire un premier cancer du sein.
Par Anne Jeanblanc. Dans Le Point
Cancer du sein: médicament de Roche homologué en Suisse
L'homologation se fonde sur les résultats d'une étude qui a montré que les patientes ayant reçu le traitement combiné par Perjeta ont vécu en moyenne six mois de plus sans aggravation de leur tumeur cancéreuse.
Un cachet d'aspirine par jour réduit les risques de mourir d'un cancer
Selon les chercheurs, le risque serait diminué de 16%.